speb/financial-data huggingface dataset:
AC8.L income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -160480.00
AC8.L income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -160480.00
AC8.L income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -160480.00
AC8.L income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -160480.00
AC8.L cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: -160480.00
AC8.L income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: -160480.00
AC8.L income_statement (annual, 2024-12-31) — Net Interest Income: 516.00
AC8.L cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: 0.00
AC8.L cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: 0.00
AC8.L income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: 516.00
AC8.L balance_sheet (annual, 2024-12-31) — Net Tangible Assets: -46431.00
AC8.L balance_sheet (quarterly, 2024-12-31) — Net Tangible Assets: -46431.00
AC8.L income_statement (annual, 2024-12-31) — Normalized EBITDA: -160480.00
AC8.L income_statement (annual, 2024-12-31) — Normalized Income: -160480.00
AC8.L cash_flow (annual, 2024-12-31) — Operating Cash Flow: -161010.00
AC8.L income_statement (annual, 2024-12-31) — Operating Income: -160996.00
AC8.L income_statement (annual, 2024-12-31) — Operating Revenue: 0.00
AC8.L balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 750000.00
AC8.L balance_sheet (quarterly, 2024-12-31) — Ordinary Shares Number: 750000.00
AC8.L balance_sheet (annual, 2024-12-31) — Other Equity Interest: 1086.00
AC8.L balance_sheet (quarterly, 2024-12-31) — Other Equity Interest: 1086.00
AC8.L cash_flow (annual, 2024-12-31) — Other Non Cash Items: -516.00
AC8.L balance_sheet (annual, 2024-12-31) — Other Payable: 10828.00
AC8.L balance_sheet (quarterly, 2024-12-31) — Other Payable: 10828.00
AC8.L balance_sheet (annual, 2024-12-31) — Other Receivables: 3.00
AC8.L balance_sheet (quarterly, 2024-12-31) — Other Receivables: 3.00
AC8.L income_statement (annual, 2024-12-31) — Otherunder Preferred Stock Dividend: 0.00
AC8.L balance_sheet (annual, 2024-12-31) — Payables: 10828.00
AC8.L balance_sheet (quarterly, 2024-12-31) — Payables: 10828.00
AC8.L balance_sheet (annual, 2024-12-31) — Prepaid Assets: 7469.00
AC8.L balance_sheet (quarterly, 2024-12-31) — Prepaid Assets: 7469.00
AC8.L income_statement (annual, 2024-12-31) — Pretax Income: -160480.00
AC8.L balance_sheet (annual, 2024-12-31) — Retained Earnings: -784617.00
AC8.L balance_sheet (quarterly, 2024-12-31) — Retained Earnings: -784617.00
AC8.L income_statement (annual, 2024-12-31) — Selling General And Administration: 160996.00
AC8.L balance_sheet (annual, 2024-12-31) — Share Issued: 750000.00
AC8.L balance_sheet (quarterly, 2024-12-31) — Share Issued: 750000.00
AC8.L cash_flow (annual, 2024-12-31) — Stock Based Compensation: 314.00
AC8.L balance_sheet (annual, 2024-12-31) — Stockholders Equity: -46431.00
AC8.L balance_sheet (quarterly, 2024-12-31) — Stockholders Equity: -46431.00
AC8.L balance_sheet (annual, 2024-12-31) — Tangible Book Value: -46431.00
AC8.L balance_sheet (quarterly, 2024-12-31) — Tangible Book Value: -46431.00
AC8.L income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
AC8.L income_statement (annual, 2024-12-31) — Tax Provision: 0.00
AC8.L income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.00
AC8.L balance_sheet (annual, 2024-12-31) — Total Assets: 7585.00
AC8.L balance_sheet (quarterly, 2024-12-31) — Total Assets: 7585.00
AC8.L balance_sheet (annual, 2024-12-31) — Total Capitalization: -46431.00
AC8.L balance_sheet (quarterly, 2024-12-31) — Total Capitalization: -46431.00
AC8.L balance_sheet (annual, 2024-12-31) — Total Debt: 0.00
AC8.L balance_sheet (quarterly, 2024-12-31) — Total Debt: 0.00
AC8.L balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: -46364.00
AC8.L balance_sheet (quarterly, 2024-12-31) — Total Equity Gross Minority Interest: -46364.00
AC8.L income_statement (annual, 2024-12-31) — Total Expenses: 160996.00
AC8.L balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 53949.00
AC8.L balance_sheet (quarterly, 2024-12-31) — Total Liabilities Net Minority Interest: 53949.00
AC8.L balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 0.00
AC8.L balance_sheet (quarterly, 2024-12-31) — Total Non Current Assets: 0.00
AC8.L balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 0.00
AC8.L balance_sheet (quarterly, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 0.00
AC8.L income_statement (annual, 2024-12-31) — Total Operating Income As Reported: -160996.00
AC8.L income_statement (annual, 2024-12-31) — Total Unusual Items: 0.00
AC8.L income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: 0.00
AC8.L balance_sheet (annual, 2024-12-31) — Working Capital: -46364.00
AC8.L balance_sheet (quarterly, 2024-12-31) — Working Capital: -46364.00
AC8.L income_statement (annual, 2025-12-31) — +Operating Expense: 172772.00
AC8.L income_statement (annual, 2025-12-31) — +Total Revenue: 0.00
AC8.L balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 729600.00
AC8.L balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 729600.00
AC8.L cash_flow (annual, 2025-12-31) — Beginning Cash Position: 113.00
AC8.L balance_sheet (annual, 2025-12-31) — Capital Stock: 7500.00
AC8.L balance_sheet (quarterly, 2025-12-31) — Capital Stock: 7500.00
AC8.L balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 209224.00
AC8.L balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 209224.00
AC8.L balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 209224.00
AC8.L balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 209224.00
AC8.L cash_flow (annual, 2025-12-31) — Change In Payable: 1561.00
AC8.L cash_flow (annual, 2025-12-31) — Change In Receivables: -32.00
AC8.L cash_flow (annual, 2025-12-31) — Change In Working Capital: 1529.00
AC8.L cash_flow (annual, 2025-12-31) — Changes In Cash: 209111.00
AC8.L balance_sheet (annual, 2025-12-31) — Common Stock: 7500.00
AC8.L balance_sheet (quarterly, 2025-12-31) — Common Stock: 7500.00
AC8.L balance_sheet (annual, 2025-12-31) — Common Stock Equity: -213207.00
AC8.L balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: -213207.00
AC8.L balance_sheet (annual, 2025-12-31) — Current Assets: 216869.00
AC8.L balance_sheet (quarterly, 2025-12-31) — Current Assets: 216869.00
AC8.L balance_sheet (annual, 2025-12-31) — Current Liabilities: 55510.00
AC8.L balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 55510.00
AC8.L income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: -167089.00
AC8.L income_statement (annual, 2025-12-31) — EBIT: -143045.00
AC8.L income_statement (annual, 2025-12-31) — EBITDA: -143045.00
AC8.L cash_flow (annual, 2025-12-31) — End Cash Position: 209224.00
AC8.L cash_flow (annual, 2025-12-31) — Financing Cash Flow: 380000.00
AC8.L cash_flow (annual, 2025-12-31) — Free Cash Flow: -170930.00
AC8.L cash_flow (annual, 2025-12-31) — Gain Loss On Investment Securities: -29545.00
AC8.L income_statement (annual, 2025-12-31) — General And Administrative Expense: 172772.00
AC8.L income_statement (annual, 2025-12-31) — Interest Expense: 24044.00
AC8.L income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 24044.00
AC8.L income_statement (annual, 2025-12-31) — Interest Income: 182.00
AC8.L income_statement (annual, 2025-12-31) — Interest Income Non Operating: 182.00
AC8.L cash_flow (annual, 2025-12-31) — Interest Received Cfi: 41.00
AC8.L balance_sheet (annual, 2025-12-31) — Invested Capital: 161292.00
AC8.L balance_sheet (quarterly, 2025-12-31) — Invested Capital: 161292.00
AC8.L cash_flow (annual, 2025-12-31) — Investing Cash Flow: 41.00
AC8.L cash_flow (annual, 2025-12-31) — Issuance Of Debt: 380000.00
AC8.L balance_sheet (annual, 2025-12-31) — Long Term Debt: 374499.00
AC8.L balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 374499.00
AC8.L balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 374499.00
AC8.L balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 374499.00
AC8.L cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 380000.00
AC8.L balance_sheet (annual, 2025-12-31) — Minority Interest: 67.00
AC8.L balance_sheet (quarterly, 2025-12-31) — Minority Interest: 67.00
AC8.L income_statement (annual, 2025-12-31) — Minority Interests: 0.00
AC8.L balance_sheet (annual, 2025-12-31) — Net Debt: 165275.00
AC8.L balance_sheet (quarterly, 2025-12-31) — Net Debt: 165275.00
AC8.L income_statement (annual, 2025-12-31) — Net Income: -167089.00
AC8.L income_statement (annual, 2025-12-31) — Net Income Common Stockholders: -167089.00
AC8.L income_statement (annual, 2025-12-31) — Net Income Continuous Operations: -167089.00
AC8.L income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -167089.00
AC8.L income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -167089.00
AC8.L cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: -167089.00
AC8.L income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: -167089.00
AC8.L income_statement (annual, 2025-12-31) — Net Interest Income: -23862.00
AC8.L cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: 380000.00
AC8.L cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: 380000.00
AC8.L income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -23862.00
AC8.L balance_sheet (annual, 2025-12-31) — Net Tangible Assets: -213207.00
AC8.L balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: -213207.00
AC8.L income_statement (annual, 2025-12-31) — Normalized EBITDA: -172590.00
AC8.L income_statement (annual, 2025-12-31) — Normalized Income: -196634.00
AC8.L cash_flow (annual, 2025-12-31) — Operating Cash Flow: -170930.00
AC8.L income_statement (annual, 2025-12-31) — Operating Income: -172772.00
AC8.L income_statement (annual, 2025-12-31) — Operating Revenue: 0.00
AC8.L balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 750000.00
AC8.L balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 750000.00
AC8.L balance_sheet (annual, 2025-12-31) — Other Equity Interest: 1399.00
AC8.L balance_sheet (quarterly, 2025-12-31) — Other Equity Interest: 1399.00
AC8.L cash_flow (annual, 2025-12-31) — Other Non Cash Items: 23862.00
AC8.L balance_sheet (annual, 2025-12-31) — Other Payable: 11840.00
AC8.L balance_sheet (quarterly, 2025-12-31) — Other Payable: 11840.00
AC8.L balance_sheet (annual, 2025-12-31) — Other Receivables: 144.00
AC8.L balance_sheet (quarterly, 2025-12-31) — Other Receivables: 144.00
AC8.L income_statement (annual, 2025-12-31) — Otherunder Preferred Stock Dividend: 0.00
AC8.L balance_sheet (annual, 2025-12-31) — Payables: 11840.00
AC8.L balance_sheet (quarterly, 2025-12-31) — Payables: 11840.00
AC8.L balance_sheet (annual, 2025-12-31) — Prepaid Assets: 7501.00
AC8.L balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 7501.00
AC8.L income_statement (annual, 2025-12-31) — Pretax Income: -167089.00
AC8.L balance_sheet (annual, 2025-12-31) — Retained Earnings: -951706.00
AC8.L balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -951706.00
AC8.L income_statement (annual, 2025-12-31) — Selling General And Administration: 172772.00
AC8.L balance_sheet (annual, 2025-12-31) — Share Issued: 750000.00
AC8.L balance_sheet (quarterly, 2025-12-31) — Share Issued: 750000.00
AC8.L cash_flow (annual, 2025-12-31) — Stock Based Compensation: 313.00
AC8.L balance_sheet (annual, 2025-12-31) — Stockholders Equity: -213207.00
AC8.L balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: -213207.00
AC8.L balance_sheet (annual, 2025-12-31) — Tangible Book Value: -213207.00
AC8.L balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: -213207.00
AC8.L income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
AC8.L income_statement (annual, 2025-12-31) — Tax Provision: 0.00
AC8.L income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.00
AC8.L balance_sheet (annual, 2025-12-31) — Total Assets: 216869.00
AC8.L balance_sheet (quarterly, 2025-12-31) — Total Assets: 216869.00
AC8.L balance_sheet (annual, 2025-12-31) — Total Capitalization: 161292.00
AC8.L balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 161292.00
AC8.L balance_sheet (annual, 2025-12-31) — Total Debt: 374499.00
AC8.L balance_sheet (quarterly, 2025-12-31) — Total Debt: 374499.00
AC8.L balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: -213140.00
AC8.L balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: -213140.00
AC8.L income_statement (annual, 2025-12-31) — Total Expenses: 172772.00
AC8.L balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 430009.00
AC8.L balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 430009.00
AC8.L balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 0.00
AC8.L balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 0.00
AC8.L balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 374499.00
AC8.L balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 374499.00
AC8.L income_statement (annual, 2025-12-31) — Total Operating Income As Reported: -172772.00
AC8.L income_statement (annual, 2025-12-31) — Total Unusual Items: 29545.00
AC8.L income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: 29545.00
AC8.L balance_sheet (annual, 2025-12-31) — Working Capital: 161359.00
AC8.L balance_sheet (quarterly, 2025-12-31) — Working Capital: 161359.00
ACA cash_flow (annual, 2021-12-31) — Gain Loss On Sale Of Business: 0.00
ACA cash_flow (annual, 2021-12-31) — Gain Loss On Sale Of PPE: -10300000.00
ACA income_statement (annual, 2021-12-31) — Gain On Sale Of Business: 0.00
ACA income_statement (annual, 2021-12-31) — Gain On Sale Of Ppe: 10300000.00
ACA income_statement (annual, 2021-12-31) — Gain On Sale Of Security: -600000.00
ACA income_statement (annual, 2021-12-31) — Impairment Of Capital Assets: 2900000.00
ACA cash_flow (annual, 2021-12-31) — Income Tax Paid Supplemental Data: 2900000.00
ACA cash_flow (annual, 2021-12-31) — Net Other Financing Charges: -6600000.00
ACA cash_flow (annual, 2021-12-31) — Net PPE Purchase And Sale: 20000000.00
ACA balance_sheet (annual, 2021-12-31) — Other Current Liabilities: 18600000.00
ACA balance_sheet (annual, 2021-12-31) — Other Properties: 507300000.00
ACA cash_flow (annual, 2021-12-31) — Purchase Of Business: -523400000.00
ACA cash_flow (annual, 2021-12-31) — Sale Of PPE: 20000000.00
ACA income_statement (annual, 2021-12-31) — Special Income Charges: 7400000.00
ACA income_statement (annual, 2021-12-31) — Total Unusual Items: 6800000.00
ACA income_statement (annual, 2021-12-31) — Total Unusual Items Excluding Goodwill: 6800000.00
ACA balance_sheet (annual, 2021-12-31) — Treasury Stock: 0.00
ACA income_statement (annual, 2021-12-31) — Write Off: 2900000.00
ACA income_statement (annual, 2022-12-31) — +Operating Expense: 262800000.00
ACA income_statement (annual, 2022-12-31) — +Total Revenue: 2242800000.00
ACA balance_sheet (annual, 2022-12-31) — Accounts Payable: 190700000.00
ACA balance_sheet (annual, 2022-12-31) — Accounts Receivable: 334200000.00
ACA balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -811300000.00
ACA balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 1684100000.00
ACA balance_sheet (annual, 2022-12-31) — Allowance For Doubtful Accounts Receivable: -5500000.00
ACA cash_flow (annual, 2022-12-31) — Asset Impairment Charge: 0.00
ACA income_statement (annual, 2022-12-31) — Average Dilution Earnings: 0.00
ACA income_statement (annual, 2022-12-31) — Basic Average Shares: 48200000.00
ACA income_statement (annual, 2022-12-31) — Basic EPS: 5.08
ACA cash_flow (annual, 2022-12-31) — Beginning Cash Position: 72900000.00
ACA balance_sheet (annual, 2022-12-31) — Buildings And Improvements: 308300000.00
ACA cash_flow (annual, 2022-12-31) — Capital Expenditure: -138000000.00
ACA cash_flow (annual, 2022-12-31) — Capital Expenditure Reported: -138000000.00
ACA balance_sheet (annual, 2022-12-31) — Capital Stock: 500000.00
ACA balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 160400000.00
ACA balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 160400000.00
ACA cash_flow (annual, 2022-12-31) — Cash Dividends Paid: -9800000.00
ACA cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: -177500000.00
ACA cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: 90700000.00
ACA cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: 174300000.00
ACA cash_flow (annual, 2022-12-31) — Change In Account Payable: 27000000.00
ACA cash_flow (annual, 2022-12-31) — Change In Accrued Expense: -13100000.00
ACA cash_flow (annual, 2022-12-31) — Change In Inventory: -26700000.00
ACA cash_flow (annual, 2022-12-31) — Change In Other Current Assets: -8500000.00
ACA cash_flow (annual, 2022-12-31) — Change In Other Working Capital: 21900000.00
ACA cash_flow (annual, 2022-12-31) — Change In Payable: 27000000.00
ACA cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: 13900000.00
ACA cash_flow (annual, 2022-12-31) — Change In Receivables: -65900000.00
ACA cash_flow (annual, 2022-12-31) — Change In Working Capital: -65300000.00
ACA cash_flow (annual, 2022-12-31) — Changes In Cash: 87500000.00
ACA balance_sheet (annual, 2022-12-31) — Common Stock: 500000.00
ACA cash_flow (annual, 2022-12-31) — Common Stock Dividend Paid: -9800000.00
ACA balance_sheet (annual, 2022-12-31) — Common Stock Equity: 2184400000.00
ACA cash_flow (annual, 2022-12-31) — Common Stock Payments: -27500000.00
ACA balance_sheet (annual, 2022-12-31) — Construction In Progress: 83700000.00
ACA income_statement (annual, 2022-12-31) — Cost Of Revenue: 1831700000.00
ACA balance_sheet (annual, 2022-12-31) — Current Accrued Expenses: 121800000.00
ACA balance_sheet (annual, 2022-12-31) — Current Assets: 856800000.00
ACA balance_sheet (annual, 2022-12-31) — Current Debt: 14700000.00
ACA balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 14700000.00
ACA balance_sheet (annual, 2022-12-31) — Current Deferred Liabilities: 40500000.00
ACA balance_sheet (annual, 2022-12-31) — Current Deferred Revenue: 40500000.00
ACA balance_sheet (annual, 2022-12-31) — Current Liabilities: 367700000.00
ACA cash_flow (annual, 2022-12-31) — Deferred Income Tax: 44800000.00
ACA cash_flow (annual, 2022-12-31) — Deferred Tax: 44800000.00
ACA cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 154100000.00
ACA income_statement (annual, 2022-12-31) — Diluted Average Shares: 48500000.00
ACA income_statement (annual, 2022-12-31) — Diluted EPS: 5.05
ACA income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: 244800000.00
ACA income_statement (annual, 2022-12-31) — EBIT: 347200000.00
ACA income_statement (annual, 2022-12-31) — EBITDA: 501300000.00
ACA cash_flow (annual, 2022-12-31) — End Cash Position: 160400000.00
ACA cash_flow (annual, 2022-12-31) — Financing Cash Flow: -177500000.00
ACA balance_sheet (annual, 2022-12-31) — Finished Goods: 130300000.00
ACA cash_flow (annual, 2022-12-31) — Free Cash Flow: 36300000.00
ACA cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of Business: -189000000.00
ACA cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of PPE: -11700000.00
ACA income_statement (annual, 2022-12-31) — Gain On Sale Of Business: 189000000.00
ACA income_statement (annual, 2022-12-31) — Gain On Sale Of Ppe: 11700000.00
ACA income_statement (annual, 2022-12-31) — Gain On Sale Of Security: -3300000.00
ACA balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: -15700000.00
ACA balance_sheet (annual, 2022-12-31) — Goodwill: 958500000.00
ACA balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 1214600000.00
ACA balance_sheet (annual, 2022-12-31) — Gross Accounts Receivable: 339700000.00
ACA balance_sheet (annual, 2022-12-31) — Gross PPE: 2010900000.00
ACA income_statement (annual, 2022-12-31) — Gross Profit: 411100000.00
ACA income_statement (annual, 2022-12-31) — Impairment Of Capital Assets: 0.00
ACA cash_flow (annual, 2022-12-31) — Income Tax Paid Supplemental Data: 21900000.00
ACA income_statement (annual, 2022-12-31) — Interest Expense: 31000000.00
ACA income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 31000000.00
ACA income_statement (annual, 2022-12-31) — Interest Income: 1100000.00
ACA income_statement (annual, 2022-12-31) — Interest Income Non Operating: 1100000.00
ACA cash_flow (annual, 2022-12-31) — Interest Paid Supplemental Data: 23600000.00
ACA balance_sheet (annual, 2022-12-31) — Inventory: 315800000.00
ACA balance_sheet (annual, 2022-12-31) — Invested Capital: 2735000000.00
ACA cash_flow (annual, 2022-12-31) — Investing Cash Flow: 90700000.00
ACA cash_flow (annual, 2022-12-31) — Issuance Of Debt: 80000000.00
ACA balance_sheet (annual, 2022-12-31) — Land And Improvements: 138700000.00
ACA balance_sheet (annual, 2022-12-31) — Long Term Debt: 535900000.00
ACA balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 535900000.00
ACA cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 80000000.00
ACA cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -220200000.00
ACA balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 973900000.00
ACA cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: 196500000.00
ACA cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: -27500000.00
ACA balance_sheet (annual, 2022-12-31) — Net Debt: 390200000.00
ACA income_statement (annual, 2022-12-31) — Net Income: 245800000.00
ACA income_statement (annual, 2022-12-31) — Net Income Common Stockholders: 244800000.00
ACA income_statement (annual, 2022-12-31) — Net Income Continuous Operations: 245800000.00
ACA income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: 245800000.00
ACA income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: 245800000.00
ACA cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: 245800000.00
ACA income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: 245800000.00
ACA income_statement (annual, 2022-12-31) — Net Interest Income: -29900000.00
ACA cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: -140200000.00
ACA cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: -140200000.00
ACA income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -29900000.00
ACA balance_sheet (annual, 2022-12-31) — Net PPE: 1199600000.00
ACA cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: 32200000.00
ACA balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 969800000.00
ACA balance_sheet (annual, 2022-12-31) — Non Current Deferred Assets: 9600000.00
ACA balance_sheet (annual, 2022-12-31) — Non Current Deferred Liabilities: 175600000.00
ACA balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Assets: 9600000.00
ACA balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Liabilities: 175600000.00
ACA income_statement (annual, 2022-12-31) — Normalized EBITDA: 303900000.00
ACA income_statement (annual, 2022-12-31) — Normalized Income: 92420200.00
ACA cash_flow (annual, 2022-12-31) — Operating Cash Flow: 174300000.00
ACA cash_flow (annual, 2022-12-31) — Operating Gains Losses: -200700000.00
ACA income_statement (annual, 2022-12-31) — Operating Income: 148300000.00
ACA income_statement (annual, 2022-12-31) — Operating Revenue: 2242800000.00
ACA balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 48400000.00
ACA balance_sheet (annual, 2022-12-31) — Other Current Assets: 46400000.00
ACA balance_sheet (annual, 2022-12-31) — Other Current Liabilities: 40500000.00
ACA balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: -15700000.00
ACA income_statement (annual, 2022-12-31) — Other Income Expense: 197800000.00
ACA balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 256100000.00
ACA cash_flow (annual, 2022-12-31) — Other Non Cash Items: -23500000.00
ACA balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 60000000.00
ACA balance_sheet (annual, 2022-12-31) — Other Non Current Liabilities: 77000000.00
ACA income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: 400000.00
ACA balance_sheet (annual, 2022-12-31) — Other Properties: 506300000.00
ACA income_statement (annual, 2022-12-31) — Otherunder Preferred Stock Dividend: 1000000.00
ACA balance_sheet (annual, 2022-12-31) — Payables: 190700000.00
ACA balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 312500000.00
ACA income_statement (annual, 2022-12-31) — Pretax Income: 316200000.00
ACA balance_sheet (annual, 2022-12-31) — Properties: 506300000.00
ACA cash_flow (annual, 2022-12-31) — Purchase Of Business: -75100000.00
ACA balance_sheet (annual, 2022-12-31) — Raw Materials: 126300000.00
ACA balance_sheet (annual, 2022-12-31) — Receivables: 334200000.00
ACA income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 1831700000.00
ACA income_statement (annual, 2022-12-31) — Reconciled Depreciation: 154100000.00
ACA cash_flow (annual, 2022-12-31) — Repayment Of Debt: -220200000.00
ACA cash_flow (annual, 2022-12-31) — Repurchase Of Capital Stock: -27500000.00
ACA balance_sheet (annual, 2022-12-31) — Retained Earnings: 515500000.00
ACA cash_flow (annual, 2022-12-31) — Sale Of Business: 271600000.00
ACA cash_flow (annual, 2022-12-31) — Sale Of PPE: 32200000.00
ACA income_statement (annual, 2022-12-31) — Selling General And Administration: 262800000.00
ACA balance_sheet (annual, 2022-12-31) — Share Issued: 48400000.00
ACA income_statement (annual, 2022-12-31) — Special Income Charges: 200700000.00
ACA cash_flow (annual, 2022-12-31) — Stock Based Compensation: 19100000.00
ACA balance_sheet (annual, 2022-12-31) — Stockholders Equity: 2184400000.00
ACA balance_sheet (annual, 2022-12-31) — Tangible Book Value: 969800000.00
ACA income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 44020200.00
ACA income_statement (annual, 2022-12-31) — Tax Provision: 70400000.00
ACA income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.22
ACA balance_sheet (annual, 2022-12-31) — Total Assets: 3340600000.00
ACA balance_sheet (annual, 2022-12-31) — Total Capitalization: 2720300000.00
ACA balance_sheet (annual, 2022-12-31) — Total Debt: 550600000.00
ACA balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 2184400000.00
ACA income_statement (annual, 2022-12-31) — Total Expenses: 2094500000.00
ACA balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 1156200000.00
ACA balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 2483800000.00
ACA balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 788500000.00
ACA income_statement (annual, 2022-12-31) — Total Operating Income As Reported: 349000000.00
ACA income_statement (annual, 2022-12-31) — Total Unusual Items: 197400000.00
ACA income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: 197400000.00
ACA balance_sheet (annual, 2022-12-31) — Treasury Stock: 0.00
ACA balance_sheet (annual, 2022-12-31) — Work In Process: 59200000.00
ACA balance_sheet (annual, 2022-12-31) — Working Capital: 489100000.00
ACA income_statement (annual, 2022-12-31) — Write Off: 0.00
ACA income_statement (annual, 2023-12-31) — +Operating Expense: 226500000.00
ACA income_statement (annual, 2023-12-31) — +Total Revenue: 2307900000.00
ACA balance_sheet (annual, 2023-12-31) — Accounts Payable: 272500000.00
ACA balance_sheet (annual, 2023-12-31) — Accounts Receivable: 357100000.00
ACA balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -932900000.00
ACA balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 1682800000.00
ACA balance_sheet (annual, 2023-12-31) — Allowance For Doubtful Accounts Receivable: -5300000.00
ACA cash_flow (annual, 2023-12-31) — Asset Impairment Charge: 0.00
ACA income_statement (annual, 2023-12-31) — Average Dilution Earnings: 0.00
ACA income_statement (annual, 2023-12-31) — Basic Average Shares: 48500000.00
ACA income_statement (annual, 2023-12-31) — Basic EPS: 3.27
ACA cash_flow (annual, 2023-12-31) — Beginning Cash Position: 160400000.00
ACA balance_sheet (annual, 2023-12-31) — Buildings And Improvements: 345600000.00
ACA cash_flow (annual, 2023-12-31) — Capital Expenditure: -203500000.00
ACA cash_flow (annual, 2023-12-31) — Capital Expenditure Reported: -203500000.00
ACA balance_sheet (annual, 2023-12-31) — Capital Stock: 500000.00
ACA balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 104800000.00
ACA balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 104800000.00
ACA cash_flow (annual, 2023-12-31) — Cash Dividends Paid: -9800000.00
ACA cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: -30800000.00
ACA cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -285800000.00
ACA cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: 261000000.00
ACA cash_flow (annual, 2023-12-31) — Change In Account Payable: 77200000.00
ACA cash_flow (annual, 2023-12-31) — Change In Accrued Expense: -14500000.00
ACA cash_flow (annual, 2023-12-31) — Change In Inventory: -83500000.00
ACA cash_flow (annual, 2023-12-31) — Change In Other Current Assets: -1800000.00
ACA cash_flow (annual, 2023-12-31) — Change In Other Working Capital: -1400000.00
ACA cash_flow (annual, 2023-12-31) — Change In Payable: 77200000.00
ACA cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: 62700000.00
ACA cash_flow (annual, 2023-12-31) — Change In Receivables: -47800000.00
ACA cash_flow (annual, 2023-12-31) — Change In Working Capital: -71800000.00
ACA cash_flow (annual, 2023-12-31) — Changes In Cash: -55600000.00
ACA balance_sheet (annual, 2023-12-31) — Common Stock: 500000.00
ACA cash_flow (annual, 2023-12-31) — Common Stock Dividend Paid: -9800000.00
ACA balance_sheet (annual, 2023-12-31) — Common Stock Equity: 2332000000.00
ACA cash_flow (annual, 2023-12-31) — Common Stock Payments: -25200000.00
ACA balance_sheet (annual, 2023-12-31) — Construction In Progress: 115500000.00
ACA income_statement (annual, 2023-12-31) — Cost Of Revenue: 1864100000.00
ACA balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 117400000.00
ACA balance_sheet (annual, 2023-12-31) — Current Assets: 912000000.00
ACA balance_sheet (annual, 2023-12-31) — Current Debt: 6800000.00
ACA balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 6800000.00
ACA balance_sheet (annual, 2023-12-31) — Current Deferred Liabilities: 34500000.00
ACA balance_sheet (annual, 2023-12-31) — Current Deferred Revenue: 34500000.00
ACA balance_sheet (annual, 2023-12-31) — Current Liabilities: 431200000.00
ACA cash_flow (annual, 2023-12-31) — Deferred Income Tax: 31800000.00
ACA cash_flow (annual, 2023-12-31) — Deferred Tax: 31800000.00
ACA cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 159500000.00
ACA income_statement (annual, 2023-12-31) — Diluted Average Shares: 48700000.00
ACA income_statement (annual, 2023-12-31) — Diluted EPS: 3.26
ACA income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: 158600000.00
ACA income_statement (annual, 2023-12-31) — EBIT: 224000000.00
ACA income_statement (annual, 2023-12-31) — EBITDA: 383500000.00
ACA cash_flow (annual, 2023-12-31) — End Cash Position: 104800000.00
ACA cash_flow (annual, 2023-12-31) — Financing Cash Flow: -30800000.00
ACA balance_sheet (annual, 2023-12-31) — Finished Goods: 148300000.00
ACA cash_flow (annual, 2023-12-31) — Free Cash Flow: 57500000.00
ACA cash_flow (annual, 2023-12-31) — Gain Loss On Sale Of Business: -6400000.00
ACA cash_flow (annual, 2023-12-31) — Gain Loss On Sale Of PPE: -28200000.00
ACA income_statement (annual, 2023-12-31) — Gain On Sale Of Business: 6400000.00
ACA income_statement (annual, 2023-12-31) — Gain On Sale Of Ppe: 28200000.00
ACA income_statement (annual, 2023-12-31) — Gain On Sale Of Security: 1700000.00
ACA balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: -16200000.00
ACA balance_sheet (annual, 2023-12-31) — Goodwill: 990700000.00
ACA balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 1261400000.00
ACA balance_sheet (annual, 2023-12-31) — Gross Accounts Receivable: 362400000.00
ACA balance_sheet (annual, 2023-12-31) — Gross PPE: 2269200000.00
ACA income_statement (annual, 2023-12-31) — Gross Profit: 443800000.00
ACA income_statement (annual, 2023-12-31) — Impairment Of Capital Assets: 0.00
ACA cash_flow (annual, 2023-12-31) — Income Tax Paid Supplemental Data: 13600000.00
ACA income_statement (annual, 2023-12-31) — Interest Expense: 28100000.00
ACA income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 28100000.00
ACA income_statement (annual, 2023-12-31) — Interest Income: 4700000.00
ACA income_statement (annual, 2023-12-31) — Interest Income Non Operating: 4700000.00
ACA cash_flow (annual, 2023-12-31) — Interest Paid Supplemental Data: 23400000.00
ACA balance_sheet (annual, 2023-12-31) — Inventory: 401800000.00
ACA balance_sheet (annual, 2023-12-31) — Invested Capital: 2900700000.00
ACA cash_flow (annual, 2023-12-31) — Investing Cash Flow: -285800000.00
ACA cash_flow (annual, 2023-12-31) — Issuance Of Debt: 160000000.00
ACA balance_sheet (annual, 2023-12-31) — Land And Improvements: 140200000.00
ACA balance_sheet (annual, 2023-12-31) — Long Term Debt: 561900000.00
ACA balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 561900000.00
ACA cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 160000000.00
ACA cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -143800000.00
ACA balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 1121000000.00
ACA cash_flow (annual, 2023-12-31) — Net Business Purchase And Sale: -118900000.00
ACA cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: -25200000.00
ACA balance_sheet (annual, 2023-12-31) — Net Debt: 463900000.00
ACA income_statement (annual, 2023-12-31) — Net Income: 159200000.00
ACA income_statement (annual, 2023-12-31) — Net Income Common Stockholders: 158600000.00
ACA income_statement (annual, 2023-12-31) — Net Income Continuous Operations: 159200000.00
ACA income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: 159200000.00
ACA income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: 159200000.00
ACA cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: 159200000.00
ACA income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: 159200000.00
ACA income_statement (annual, 2023-12-31) — Net Interest Income: -23400000.00
ACA cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: 16200000.00
ACA cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: 16200000.00
ACA income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: -23400000.00
ACA cash_flow (annual, 2023-12-31) — Net Other Financing Charges: -12000000.00
ACA cash_flow (annual, 2023-12-31) — Net Other Investing Changes: 36600000.00
ACA balance_sheet (annual, 2023-12-31) — Net PPE: 1336300000.00
ACA cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: 36600000.00
ACA balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 1070600000.00
ACA balance_sheet (annual, 2023-12-31) — Non Current Deferred Assets: 6800000.00
ACA balance_sheet (annual, 2023-12-31) — Non Current Deferred Liabilities: 179600000.00
ACA balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Assets: 6800000.00
ACA balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Liabilities: 179600000.00
ACA income_statement (annual, 2023-12-31) — Normalized EBITDA: 383500000.00
ACA income_statement (annual, 2023-12-31) — Normalized Income: 159200000.00
ACA cash_flow (annual, 2023-12-31) — Operating Cash Flow: 261000000.00
ACA cash_flow (annual, 2023-12-31) — Operating Gains Losses: -34600000.00
ACA income_statement (annual, 2023-12-31) — Operating Income: 217300000.00
ACA income_statement (annual, 2023-12-31) — Operating Revenue: 2307900000.00
ACA balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 48562279.00
ACA balance_sheet (annual, 2023-12-31) — Other Current Assets: 48300000.00
ACA balance_sheet (annual, 2023-12-31) — Other Equity Adjustments: -16200000.00
ACA income_statement (annual, 2023-12-31) — Other Income Expense: 2000000.00
ACA balance_sheet (annual, 2023-12-31) — Other Intangible Assets: 270700000.00
ACA cash_flow (annual, 2023-12-31) — Other Non Cash Items: -7000000.00
ACA balance_sheet (annual, 2023-12-31) — Other Non Current Assets: 61400000.00
ACA balance_sheet (annual, 2023-12-31) — Other Non Current Liabilities: 73200000.00
ACA income_statement (annual, 2023-12-31) — Other Non Operating Income Expenses: 2000000.00
ACA income_statement (annual, 2023-12-31) — Other Operating Expenses: -34600000.00
ACA income_statement (annual, 2023-12-31) — Otherunder Preferred Stock Dividend: 600000.00
ACA balance_sheet (annual, 2023-12-31) — Payables: 272500000.00
ACA balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 389900000.00
ACA income_statement (annual, 2023-12-31) — Pretax Income: 195900000.00
ACA balance_sheet (annual, 2023-12-31) — Properties: 546900000.00
ACA cash_flow (annual, 2023-12-31) — Purchase Of Business: -120900000.00
ACA balance_sheet (annual, 2023-12-31) — Raw Materials: 210800000.00
ACA balance_sheet (annual, 2023-12-31) — Receivables: 357100000.00
ACA income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 1864100000.00
ACA income_statement (annual, 2023-12-31) — Reconciled Depreciation: 159500000.00
ACA cash_flow (annual, 2023-12-31) — Repayment Of Debt: -143800000.00
ACA cash_flow (annual, 2023-12-31) — Repurchase Of Capital Stock: -25200000.00
ACA balance_sheet (annual, 2023-12-31) — Retained Earnings: 664900000.00
ACA cash_flow (annual, 2023-12-31) — Sale Of Business: 2000000.00
ACA cash_flow (annual, 2023-12-31) — Sale Of PPE: 36600000.00
ACA income_statement (annual, 2023-12-31) — Selling General And Administration: 261100000.00
ACA balance_sheet (annual, 2023-12-31) — Share Issued: 48562279.00
ACA income_statement (annual, 2023-12-31) — Special Income Charges: 34600000.00
ACA cash_flow (annual, 2023-12-31) — Stock Based Compensation: 23900000.00
ACA balance_sheet (annual, 2023-12-31) — Stockholders Equity: 2332000000.00
ACA balance_sheet (annual, 2023-12-31) — Tangible Book Value: 1070600000.00
ACA income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 0.00
ACA income_statement (annual, 2023-12-31) — Tax Provision: 36700000.00
ACA income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.19
ACA balance_sheet (annual, 2023-12-31) — Total Assets: 3577900000.00
ACA balance_sheet (annual, 2023-12-31) — Total Capitalization: 2893900000.00
ACA balance_sheet (annual, 2023-12-31) — Total Debt: 568700000.00
ACA balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 2332000000.00
ACA income_statement (annual, 2023-12-31) — Total Expenses: 2090600000.00
ACA balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 1245900000.00
ACA balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 2665900000.00
ACA balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 814700000.00
ACA income_statement (annual, 2023-12-31) — Total Operating Income As Reported: 217300000.00
ACA income_statement (annual, 2023-12-31) — Total Unusual Items: 36300000.00
ACA income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: 36300000.00
ACA balance_sheet (annual, 2023-12-31) — Work In Process: 42700000.00
ACA balance_sheet (annual, 2023-12-31) — Working Capital: 480800000.00
ACA income_statement (annual, 2023-12-31) — Write Off: 0.00
ACA cash_flow (quarterly, 2024-09-30) — Asset Impairment Charge: 0.00
ACA income_statement (quarterly, 2024-09-30) — Average Dilution Earnings: 0.00
ACA cash_flow (quarterly, 2024-09-30) — Gain Loss On Sale Of Business: 23000000.00
ACA cash_flow (quarterly, 2024-09-30) — Gain Loss On Sale Of PPE: -2500000.00
ACA income_statement (quarterly, 2024-09-30) — Gain On Sale Of Business: -23000000.00
ACA income_statement (quarterly, 2024-09-30) — Gain On Sale Of Ppe: 2500000.00
ACA income_statement (quarterly, 2024-09-30) — Gain On Sale Of Security: -2700000.00
ACA income_statement (quarterly, 2024-09-30) — Impairment Of Capital Assets: 0.00
ACA cash_flow (quarterly, 2024-09-30) — Net PPE Purchase And Sale: 6600000.00
ACA income_statement (quarterly, 2024-09-30) — Otherunder Preferred Stock Dividend: 0.00
ACA cash_flow (quarterly, 2024-09-30) — Purchase Of Business: -34700000.00
ACA cash_flow (quarterly, 2024-09-30) — Sale Of PPE: 6600000.00
ACA income_statement (quarterly, 2024-09-30) — Special Income Charges: -20500000.00
ACA income_statement (quarterly, 2024-09-30) — Total Unusual Items: -2700000.00
ACA income_statement (quarterly, 2024-09-30) — Total Unusual Items Excluding Goodwill: -2700000.00
ACA balance_sheet (quarterly, 2024-09-30) — Treasury Stock: 800000.00
ACA income_statement (quarterly, 2024-09-30) — Write Off: 0.00
ACA income_statement (annual, 2024-12-31) — +Operating Expense: 317600000.00
ACA income_statement (annual, 2024-12-31) — +Total Revenue: 2569900000.00
ACA balance_sheet (annual, 2024-12-31) — Accounts Payable: 237300000.00
ACA balance_sheet (annual, 2024-12-31) — Accounts Receivable: 350200000.00
ACA balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -929500000.00
ACA balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 1696500000.00
ACA balance_sheet (annual, 2024-12-31) — Allowance For Doubtful Accounts Receivable: -10300000.00
ACA balance_sheet (quarterly, 2024-12-31) — Allowance For Doubtful Accounts Receivable: -10300000.00
ACA cash_flow (annual, 2024-12-31) — Asset Impairment Charge: 5800000.00
ACA cash_flow (quarterly, 2024-12-31) — Asset Impairment Charge: 0.00
ACA income_statement (annual, 2024-12-31) — Average Dilution Earnings: 0.00
ACA income_statement (quarterly, 2024-12-31) — Average Dilution Earnings: 0.00
ACA income_statement (annual, 2024-12-31) — Basic Average Shares: 48600000.00
ACA income_statement (annual, 2024-12-31) — Basic EPS: 1.92
ACA cash_flow (annual, 2024-12-31) — Beginning Cash Position: 104800000.00
ACA balance_sheet (annual, 2024-12-31) — Buildings And Improvements: 366400000.00
ACA cash_flow (annual, 2024-12-31) — Capital Expenditure: -189700000.00
ACA cash_flow (annual, 2024-12-31) — Capital Expenditure Reported: -189700000.00
ACA balance_sheet (annual, 2024-12-31) — Capital Stock: 500000.00
ACA balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 187300000.00
ACA balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 187300000.00
ACA cash_flow (annual, 2024-12-31) — Cash Dividends Paid: -9700000.00
ACA cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: 1089400000.00
ACA cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -1508900000.00
ACA cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: 502000000.00
ACA cash_flow (annual, 2024-12-31) — Change In Account Payable: -48300000.00
ACA cash_flow (annual, 2024-12-31) — Change In Accrued Expense: 41600000.00
ACA cash_flow (annual, 2024-12-31) — Change In Inventory: 59200000.00
ACA cash_flow (annual, 2024-12-31) — Change In Other Current Assets: -4300000.00
ACA cash_flow (annual, 2024-12-31) — Change In Other Working Capital: 66800000.00
ACA cash_flow (annual, 2024-12-31) — Change In Payable: -48300000.00
ACA cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: -6700000.00
ACA cash_flow (annual, 2024-12-31) — Change In Receivables: 70000000.00
ACA cash_flow (annual, 2024-12-31) — Change In Working Capital: 185000000.00
ACA cash_flow (annual, 2024-12-31) — Changes In Cash: 82500000.00
ACA balance_sheet (annual, 2024-12-31) — Common Stock: 500000.00
ACA cash_flow (annual, 2024-12-31) — Common Stock Dividend Paid: -9700000.00
ACA balance_sheet (annual, 2024-12-31) — Common Stock Equity: 2428200000.00
ACA cash_flow (annual, 2024-12-31) — Common Stock Payments: -10600000.00
ACA balance_sheet (annual, 2024-12-31) — Construction In Progress: 129700000.00
ACA income_statement (annual, 2024-12-31) — Cost Of Revenue: 2054700000.00
ACA balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 166400000.00
ACA balance_sheet (annual, 2024-12-31) — Current Assets: 954000000.00
ACA balance_sheet (annual, 2024-12-31) — Current Debt: 12100000.00
ACA balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 12100000.00
ACA balance_sheet (annual, 2024-12-31) — Current Deferred Liabilities: 100200000.00
ACA balance_sheet (annual, 2024-12-31) — Current Deferred Revenue: 100200000.00
ACA balance_sheet (annual, 2024-12-31) — Current Liabilities: 516000000.00
ACA cash_flow (annual, 2024-12-31) — Deferred Income Tax: 25200000.00
ACA cash_flow (annual, 2024-12-31) — Deferred Tax: 25200000.00
ACA cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 195000000.00
ACA income_statement (annual, 2024-12-31) — Diluted Average Shares: 48800000.00
ACA income_statement (annual, 2024-12-31) — Diluted EPS: 1.91
ACA income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: 93400000.00
ACA income_statement (annual, 2024-12-31) — EBIT: 200900000.00
ACA income_statement (annual, 2024-12-31) — EBITDA: 395900000.00
ACA cash_flow (annual, 2024-12-31) — End Cash Position: 187300000.00
ACA cash_flow (annual, 2024-12-31) — Financing Cash Flow: 1089400000.00
ACA balance_sheet (annual, 2024-12-31) — Finished Goods: 176600000.00
ACA cash_flow (annual, 2024-12-31) — Free Cash Flow: 312300000.00
ACA cash_flow (annual, 2024-12-31) — Gain Loss On Sale Of Business: 2100000.00
ACA cash_flow (quarterly, 2024-12-31) — Gain Loss On Sale Of Business: -1400000.00
ACA cash_flow (annual, 2024-12-31) — Gain Loss On Sale Of PPE: -10300000.00
ACA cash_flow (quarterly, 2024-12-31) — Gain Loss On Sale Of PPE: -1900000.00
ACA income_statement (annual, 2024-12-31) — Gain On Sale Of Business: -2100000.00
ACA income_statement (quarterly, 2024-12-31) — Gain On Sale Of Business: 1400000.00
ACA income_statement (annual, 2024-12-31) — Gain On Sale Of Ppe: 10300000.00
ACA income_statement (quarterly, 2024-12-31) — Gain On Sale Of Ppe: 1900000.00
ACA income_statement (annual, 2024-12-31) — Gain On Sale Of Security: -4300000.00
ACA income_statement (quarterly, 2024-12-31) — Gain On Sale Of Security: 1200000.00
ACA balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: -17700000.00
ACA balance_sheet (annual, 2024-12-31) — Goodwill: 1361200000.00
ACA balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 1699500000.00
ACA balance_sheet (annual, 2024-12-31) — Gross Accounts Receivable: 360500000.00
ACA balance_sheet (quarterly, 2024-12-31) — Gross Accounts Receivable: 360500000.00
ACA balance_sheet (annual, 2024-12-31) — Gross PPE: 3058900000.00
ACA income_statement (annual, 2024-12-31) — Gross Profit: 515200000.00
ACA income_statement (annual, 2024-12-31) — Interest Expense: 70900000.00
ACA income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 70900000.00
ACA income_statement (annual, 2024-12-31) — Interest Income: 7500000.00
ACA income_statement (annual, 2024-12-31) — Interest Income Non Operating: 7500000.00
ACA cash_flow (annual, 2024-12-31) — Interest Paid Supplemental Data: 50300000.00
ACA balance_sheet (annual, 2024-12-31) — Inventory: 359900000.00
ACA balance_sheet (annual, 2024-12-31) — Invested Capital: 4117100000.00
ACA cash_flow (annual, 2024-12-31) — Investing Cash Flow: -1508900000.00
ACA cash_flow (annual, 2024-12-31) — Issuance Of Debt: 1635000000.00
ACA cash_flow (quarterly, 2024-12-31) — Issuance Of Debt: 700000000.00
ACA balance_sheet (annual, 2024-12-31) — Land And Improvements: 158300000.00